Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological and Clinical Effectiveness and Tolerability of Tetravalent Inactivated Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

NCT06286488 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT06286488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06286488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological and Clinical Effectiveness and Tolerability of Tetravalent Inactivated Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
Lead sponsor
Medical University of Warsaw
Phase
Phase 4
Overall status
Unknown status
Start date
September 15, 2020
Completion date
May 1, 2026
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly infection, influenza, obesity, pregnancy; infection, tolerance, vaccine adverse reaction, vaccine reaction